Company overview
Basic information
Company name
Gnp, MB
Company code
305775282
VAT code
LT100014638812
Registered address
Vilnius, V. Nagevičiaus g. 3, LT-08237
Registration date
2021-05-20
Company age: 5 y. 5 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://gnprecision.com
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Machining of metals
Ownership form
Private without foreign capital
MB "Gnp"
Company code: 305775282
Address: Vilnius, V. Nagevičiaus g. 3, LT-08237
VAT code: LT100014638812
Description
This description was generated by artificial intelligence.
Gnp, MB (company code 305775282) is an operational private small partnership registered in 2021. It is classified as a micro company within the sector of national private non-financial companies and operates under private ownership, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. Governance is CEO only. The company is registered in Vilnius, at V. Nageviciaus g. 3, LT-08237, Vilniaus m. sav., Vilniaus apskr. Its core activity is EVRK C.25.53.00, Machining of metals. Financially, the company reported revenue of €805.5K in 2025, up 30.7% year on year, with net profit of €88.0K and a profit margin of 10.9%. Equity stood at €220.5K and total assets at €602.3K, while liabilities were €381.8K. Compared with 2024, both revenue and profit increased, and the equity base also strengthened. Staffing has expanded as well: average headcount reached 7 so far in 2026, up from 5 in 2025, while the average monthly wage rose to €2,555.41 so far in 2026 from €2,341.72 in 2025.
Download a detailed company report
Make confident decisions with all the information about Gnp, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.